cal responses such as inflammatory or immune responses. iNOS and COX-2 are known to produce pro-inflammatory mediators, such as NO and prostaglandins at inflammatory sites. In particular, iNOS stimulates the oxidative deamination of L-arginine to produce NO, a potent pro-inflammatory mediator.
5) COX-2 is another enzyme that plays a key role in the mediation of inflammation by stimulating the biosynthesis of prostaglandins. In contrast to COX-1, COX-2 is barely detectable under normal physiological conditions, but it can be rapidly induced by pro-inflammatory mediators and mitogenic stimuli, such as cytokines, endotoxins, growth factors, oncogenes, and phorbol esters.
Cornuside ( Fig. 1 ) is a secoiridoid glucoside compound that was found in the fruit of Cornus officinalis SIEB. et ZUCC., which is used as a traditional oriental medicine for curing inflammatory diseases and invigorating blood circulation. Crude extract of the fruit of Cornus officinalis (Corni Fructus) was reported to possess such pharmacological actions as anti-neoplasm, anti-inflammation, and anti-dia-betes. [6] [7] [8] [9] Studies have also shown that cornuside could suppress the expression of cytokine-induced pro-inflammatory and adhesion molecules in human endothelial cells, and could protect cultured rat cortical cells against damage induced by oxygen-glucose deprivation. 10, 11) Furthermore, cornuside has been demonstrated to inhibit LPS-induced NO production in cultured mouse macrophages. 12) However, no report has been issued on the mechanism underlying its antiinflammatory effects in murine macrophage cells. Therefore, we investigated the anti-inflammatory property and molecular basis of action of cornuside in RAW 264.7 macrophage cells stimulated by LPS.
MATERIALS AND METHODS
Materials Cornuside (purity Ͼ99.0%, CAS No. 131189-57-6) with the molecular formula C 24 H 30 O 14 (molecular weight: 542.49) was provided by the Shandong Engineering Research Center for Nature Drug (Yantai, China). Dulbecco's modified Eagle's medium (DMEM), Gibco TM fetal bovine serum (FBS), penicillin, streptomycin, two-step MMLV Platinum SYBR Green qPCR SuperMix-UDG kit and Novex ECL HRP Chemiluminescent substrate reagent kits were from Invitrogen (San Diego, CA, U.S.A.). Griess reagent, NaNO 2 , bicinchoninic acid (BCA) protein assay kit, protein extraction kit, horseradish peroxidase (HRP)-conjugated and Cy3-conjugated goat-anti-rabbit immunoglobulin G (IgG) antibodies were purchased from Beyotime Institute of Biotechnology (Haimen, Jiangsu, China). Antibodies for iNOS, COX-2, and p65 were obtained from Cell Signaling Technology (Danvers, Massachusetts, U.S.A.). Antibodies for TNF-a, IL-6, IL-1b, IkB-a, phosphorylated (p)-IkB-a, extracellular-signal-related kinase (ERK), p-ERK, p38, p-p38, c-Jun N-terminal kinase (JNK), p-JNK, poly(ADP-ribose) polymerase (PARP), and b-actin were from Santa Cruz (Santa Cruz, CA, U.S.A.). PD98059 (a specific inhibitor of ERK1/2), SB203580 (a specific inhibitor of p38), SP600125 (a specific inhibitor of JNK1/2), and PDTC (a specific inhibitor of NF-kB) were purchased from Calbiochem (San Diego, CA, U.S.A.). Enzyme linked immunosorbent assay (ELISA) kits for PGE 2 , TNF-a, IL-6, and IL-1b were from Dakewe Biotech Co., Ltd. (Beijing, China). Lipopolysaccharide from Escherichia coli, serotype 0111:B4, dimethyl sulfoxide (DMSO), Triton X-100, aprotinin, leupeptin, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and all other chemicals were purchased from SigmaAldrich (St. Louis, MO, U.S.A.).
Macrophage Culture and Sample Treatment Primary mouse peritoneal macrophages were isolated as described previously. 13) Briefly, male BALB/c mice, 2 months old (house section of Yanbian University Health Science Center, China), were injected intraperitoneally (i.p.) with 3 ml sterile 2% soluble starch in NaCl prepared with pyrogen-free distilled water. Mice were euthanized after 3 d, and then killed by cervical dislocation. Peritoneal macrophages were collected by lavage using phosphate-buffered saline (PBS). The experiments were performed in compliance with the guidelines approved by Institutional Animal Care and Use Committee of Yanbian University School of Medical Sciences.
The RAW 264.7 macrophage cell line was obtained from the China Center for Type Culture Collection (Shanghai, China). Primary mouse peritoneal macrophages and RAW 264.7 cells were grown at 37°C in DMEM supplemented with 10% FBS, penicillin (100 units/ml), and streptomycin sulfate (100 mg/ml) in a humidified 5% CO 2 atmosphere. Cells were incubated with cornuside at the indicated concentrations, and then stimulated with LPS 1 mg/ml for the indicated time.
MTT Assay for RAW 264.7 and Primary Mouse Macrophage Cell Viability RAW 264.7 cells (1ϫ10 4 cells/well) and primary mouse peritoneal macrophages (1ϫ10 5 cells/well) were plated in 96-well plates. Cytotoxicity studies were performed at 24 h following treatment of cells with various concentrations of cornuside. At 24 h prior to culture termination, 20 ml of the MTT solution (5 mg/ml in a PBS, pH 7.4) was added and the cells were cultured continuously for 4 h. After that, the supernatant was carefully removed and then 150 ml DMSO was added into each well for solubilization and the optical density at 540 nm was measured by a microplate reader (Bio-Rad Labs, Sunnyvale, CA, U.S.A.).
Nitric Oxide Determination RAW 264.7 cells were plated at 2ϫ10 5 cells/well in 24-well plates and then incubated with LPS (1 mg/ml) and various concentrations (3, 10, 30 mM) of cornuside for 18 h. Nitric oxide produced in culture media was assayed by quantification of the stable end product of NO oxidation-nitrite (NO 2Ϫ ) using the Griess reagent as described previously. 14) Briefly, the incubation medium of RAW 264.7 cells was collected after the treatment and centrifuged at 12000ϫg for 5 min. Fifty-microliter volumes of supernatant and 100 ml Griess reagent were reacted for 15 min and the nitrite content was measured by absorbance at 540 nm. Fresh culture medium was used as the blank in all experiments. The NO concentration in the samples was calculated using a standard curve prepared with sodium nitrite. PGE 2 and Cytokine Assays RAW 264.7 cells were plated at 2ϫ10 5 cells/well in 24-well plates for PGE 2 , TNFa, IL-6, and IL-1b assay. The cells were incubated with LPS (1 mg/ml) and various concentrations of cornuside for 18 h. The amounts of PGE 2 , TNF-a, IL-6, and IL-1b in the cell culture supernatant were measured using ELISA kits according to the manufacturer's instructions.
Western Blot Analysis After RAW 264.7 cells were treated with LPS and cornuside, whole cell extract, nuclear and cytoplasmic proteins were prepared by using a protein extraction kit (Beyotime) according to the manufacturer's protocol. The protein concentration was measured by the BCA method. Samples (20-50 mg total protein) were separated on 8-10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membranes. After blocking with 5% nonfat milk in TBST (0.1%) for 2 h at room temperature, the membranes were incubated with primary antibody and then incubated with the conjugated secondary antibodies. The membrane was incubated with ECL detection kits for 1 min and then exposed to X-ray film. The intensity of the immunoreactive bands was determined using a densitometric analysis program (Image Gauge V3.12; Fuji Photo Film, Tokyo, Japan).
RNA Preparation and Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
The expression levels of iNOS and COX-2 transcripts from the treated cells were evaluated by RT-PCR using b-actin as an internal control. RAW 264.7 cells were plated at 1ϫ10 6 cells/well in 12-well plates and then incubated with LPS (1 mg/ml) and various concentrations of cornuside for 6 h. Total RNA was prepared by a Trizol Reagent Kit according to the manufacturer's protocol. Two micrograms total RNA was reverse-transcribed with M-MuLV Reverse Transcriptase Kit to obtain cDNA. Real-time PCR was performed in an ABI7500 real-time PCR instrument (Applied Biosystems) with the SYBR Green qPCR SuperMix-UDG Kit. A melting curve analysis was carried out after amplification to verify the accuracy of the amplicon. PCR primers used in this study are listed below: sense strand iNOS, 5Ј-AATGGCAACATCAGG-TCGGC-CATCACT-3Ј; antisense strand iNOS, 5Ј-GCTG-TGTGT-CACAGAAGTCTCGAA-CTC-3Ј; sense strand COX-2, 5Ј-GGAGAGACTATCAAGATAGT-3Ј; antisense strand COX-2, 5Ј-ATGGTCAGTAGACTT-TTACA-3Ј; and sense strand bactin, 5Ј-TCATGAAGTGTGACGTTGACATCCGT-3Ј; antisense strand b-actin, 5Ј-CCTAGAAGCATTTGCGGTG-CACGATG-3Ј. After amplification, portions of the PCR reactions were electrophoresed on 2% agarose gel, and visualized under UV after ethidium bromide staining.
Statistical Analysis Data are presented as the meansϮ standard deviation (S.D.) of at least five replicates. Statistical evaluation of the data was performed using analysis of variance (ANOVA), followed by Dunnett's post-hoc test. Results with pϽ0.05 were considered statistically significant.
RESULTS

Cornuside Inhibits NO and PGE 2 Productions in LPSStimulated RAW 264.7 Cells
To evaluate the anti-inflammatory activity of cornuside, the effects of cornuside on NO and PGE 2 productions stimulated by LPS in RAW 264.7 cells were first investigated. As shown in Fig. 2A , LPS (1 mg/ml) increased NO production by approximately 4.3 fold, but when cornuside was pretreated at 3, 10, and 30 mM for 1 h before LPS was treated, NO production was found to have decreased by 27.5, 64.7, and 67.6%, respectively. L-N 6 -(1-Iminoethyl) lysine (L-NIL, 10 mM) was used as a positive NO production inhibitor. In addition, cornuside was shown to significantly attenuate the production of PGE 2 in a dose-dependent manner (Fig. 2B) . NS-398 was used as a COX-2 selective inhibitor and exerted a significant inhibitory effect upon PGE 2 production.
Cornuside Inhibits the Release and Protein Expressions of TNF-a a, IL-6, and IL-1b b in LPS-Stimulated RAW 264.7 Cells To assess the anti-inflammatory property of cornuside, the effects of cornuside on LPS-stimulated production of pro-inflammatory cytokines in RAW 264.7 cells were investigated. As shown in Figs. 3A, B, and C, stimulation with LPS resulted in the overproduction of TNF-a, IL-6, and IL-1b compared with the vehicle-treated group. In contrast, treatment with cornuside inhibited the production and protein expression of TNF-a, IL-6, and IL-1b in a dose-dependent manner. Treatment with cornuside at 3, 10, and 30 mM led to 6.3, 12.1, and 50.8% inhibition of LPS-stimulated TNF-a production, respectively (Fig. 3A) . Likewise, over the same concentration range, cornuside reduced IL-6 secretion by 0.1, 50.1, and 75.7%, respectively (Fig. 3B) . For inhibition of IL-1b production, the same dose of cornuside caused 16.2, 51.1, and 55.4% inhibition, respectively (Fig.  3C) .
Cytotoxicity Study of Cornuside on RAW 264.7 and Primary Mouse Macrophage Cells To investigate whether the inhibitory effect of cornuside on inflammatory mediator production and pro-inflammatory cytokines release is due to a cytotoxic effect in macrophages, the cytotoxicity of cornuside was assessed. Since, RAW 264.7 is a cell line established from a tumor induced by Abelson murine leukemia virus, the cytotoxic activity of cornuside was tested in both RAW 264.7 cells and starch-elicited primary mouse peritoneal macrophages. Cells were treated with cornuside at a dose of 1, 5, 10, 20, 40, 60, 80, and 100 mM for 24 h. The results showed that treatment with cornuside did not affect the RAW 264.7 cell viability at doses ranging from 1 to 100 mM, and in primary mouse peritoneal macrophages, cornuside had no cytotoxic effect at doses ranging from 1 to 80 mM (Fig. 4) .
Cornuside Inhibits Protein and mRNA Expressions of iNOS and COX-2 in LPS-Stimulated RAW 264.7 Cells
It is well known that LPS strongly upregulates iNOS and COX-2 levels in RAW 264.7 cells. To determine whether the inhibitory effects of cornuside on NO and PGE 2 productions were related to the modulation of iNOS and COX-2 expressions, Western blotting and RT-PCR were used. As shown in Fig. 5A , cornuside concentration-dependently suppressed the expressions of iNOS and COX-2 at the protein level in LPSstimulated RAW 264.7 cells. Furthermore, RT-PCR analysis showed that the expressions of iNOS and COX-2 mRNA were positively correlated with their protein expressions (Fig.  5B) . These results suggest that cornuside attenuates the productions of NO and PGE 2 by inhibiting the expressions of iNOS and COX-2 in LPS-stimulated macrophage cells.
Cornuside Inhibits the Nuclear Translocation of NFk kB and Phosphorylation of Ik kB-a a in LPS-Stimulated RAW 264.7 Cells The activation of NF-kB is critically required for the activation of pro-inflammatory mediators, such as, iNOS, COX-2, TNF-a, IL-6, and IL-1b in LPS-stimulated macrophages. 15) In unstimulated cells, NF-kB is localized to the cytosol due to its binding with IkB. However, when cells are activated by LPS, IkB is phosphorylated by IkB kinase and degraded, and the NF-kB so released is translocated into the nucleus. Thus, to investigate whether cornuside prevents the translocation of the p65 subunit of NF-kB from the cytosol to the nucleus, Western blot was carried out in the nuclear and cytosolic fraction of RAW 264.7 cells. As shown in Fig. 6A , the p65 subunit of NF-kB was translocated into the nucleus after LPS challenge. However, treatment of cornuside markedly inhibited translocation of the p65 in a dose-dependent fashion. Then the effect of cornuside on LPS-induced phosphorylation and degradation of IkB-a was studied to examine the molecular mechanisms by which cornuside inhibits NF-kB transcriptional activity. As shown in Fig. 6B , cornuside significantly blocked the LPS-stimulated phosphorylation and degradation of IkB-a. These findings indicate that cornuside prevents the translocation of NF-kB by blocking IkB-a phosphorylation and degradation in LPS-stimulated RAW 264.7 cells.
Cornuside Inhibits the Activation of Mitogen-Activated Protein Kinases (MAPKs) in LPS-Stimulated RAW 264.7 Cells MAPKs play critical roles in the regulation of cell growth and differentiation, and control cellular responses to cytokines and stresses. In particular, MAPKs cascades are known to be rate-limiting for the LPS-stimulated induction of inflammatory mediators in RAW 264.7 cells. 16) To investigate whether the inhibition of inflammatory response by cornuside is mediated through the MAPKs pathway, MAPKs phosphorylation was examined by Western blot in RAW 264.7 cells pretreated with cornuside and then with LPS. As shown in Fig. 7 , cornuside suppressed the LPS-stimulated phosphorylations of ERK1/2, p38, and JNK1/2 in a concentration-dependent manner. On the other hand, the expressions of non-phosphorylated ERK1/2, p38, and JNK1/2 were unaffected by LPS or by cornuside and LPS. Cells were pretreated with different concentrations (3, 10, 30 mM) of cornuside for 1 h, and then with LPS (1 mg/ml) for 1 h. Nuclear extracts were prepared for the Western blot of p65 NF-kB in nuclear fraction, and p65 NF-kB, p-IkB-a, IkB-a in cytosol fraction, as described in Materials and Methods. PDTC (20 mM) is a specific inhibitor of NF-kB. b-Actin and PARP were used as internal controls. The data shown are representative of five independent experiments. Density ratios versus b-actin were measured using a densitometer.
DISCUSSION
Corni Fructus mainly contains five kinds of chemical constituents: iridoid glycosides, tannins, polysaccharides, organic acids, and esters. Among them, iridoids, a group of non-volatile compounds consisting of cyclic monoterpenes with a cyclopentane ring, exist usually as glycosidic forms. The iridoid glycosides of Corni Fructus are consisted of cornuside, dehydromorroniaglycone, loganin, morroniside, sweroside, swertiamarin, verbenalin, etc., which have been known to exhibit anti-oxidant, anti-inflammatory, and anticancer activities. [17] [18] [19] [20] As aforementioned, cornuside, the structure of which is a galloyl ester of secologanol, 21) possesses marked protective effects on various experimental models. [10] [11] [12] Previous studies have revealed that the aqueous extract of Corni Fructus exerts anti-inflammatory effects in LPS-activated RAW 264.7 macrophages, but its biologically active constituents have not been characterized. 7, 8) In light of the earlier report that some iridoid glycosides ameliorate inflammatory reactions by inhibiting inflammatory mediators, 22) cornuside is also likely to contribute to the observed antiinflammatory activity. As anticipated, cornuside was subsequently shown to downregulate the levels of TNF-a, IL-6, and NO production in resident murine macrophages stimulated by LPS, 12) which is in agreement with our results. Taking it a step further, the current study has demonstrated that cornuside inhibits inflammatory response in LPS-induced RAW 264.7 cells, and that its anti-inflammatory property may be through suppression of NF-kB and MAPKs activation. To the best of our knowledge, the present work is the first to describe the molecular mechanism of cornuside action in a macrophage model.
Macrophages are widely distributed throughout the body, and play an important role in the initiation and amplification of a variety of inflammatory diseases. Therefore, the development of methods to reduce the number of activated macrophages, to inhibit the activation signals and/or their specific macrophage receptors, or to selectively counteract the macrophage products that act as disease amplifiers has been suggested as a promising therapeutic approach against various inflammatory diseases. 23) In this study, cornuside was found to significantly reduce the production of NO and PGE 2 in a dose-dependent manner in LPS-stimulated RAW 264.7 macrophages. The Western blot and RT-PCR assay showed that treatment with cornuside inhibits expression of both iNOS and COX-2 mRNA and protein. The MTT assay confirmed that these inhibitory effects of cornuside are not due to cytotoxicity. More specifically, cornuside did not affect the RAW 264.7 cell viability even at the 100 mM, and had no cytotoxic effect at a concentration of 80 mM in the primary mouse peritoneal macrophages. These data propose the good safety profile of cornuside in vitro. However, the in vivo safety profile needs to be further evaluated.
NO is a highly reactive oxidant that is produced through the action of iNOS and participates in diverse biological effects such as the regulation of vascular inflammation, neurotransmission, and apoptosis. 24) Numerous studies have revealed that excessive NO production is important in the pathogenesis of inflammation and can lead to tissue damage. 5) In fact, several NO induction inhibitors, such as dexamethasone, have been reported to exert anti-inflammatory effects by preventing iNOS expression. Cornuside significantly inhibited NO production of activated macrophages and decreased the levels of iNOS mRNA and protein, suggesting that the specific inhibition of the iNOS gene may be responsible for the anti-inflammatory capacity of this compound.
The mechanism of action of various anti-inflammatory drugs is at least shared by the inhibition of prostaglandin (PG) synthesis, which is mediated by COX. 25) Of the two isoforms of COX, COX-1 has been suggested to provide a physiologic level of PGs for normal platelet, stomach, and kidney function. On the other hand, COX-2 has been found to be highly induced at inflammatory sites in animals as well as patients with inflammatory diseases. PGE 2 has been implicated as one of the strongest inflammatory mediators in pathophysiologic processes. It is transformed from arachidonic acid via the COX-2 catalytic reaction. 26) As mentioned above, cornuside significantly attenuated PGE 2 production, and inhibited the COX-2 mRNA and protein expressions, respectively, in a dose-dependent way. Thus, it is inferred that anti-inflammatory effects of cornuside might be attributed to its suppressive activity on PGE 2 production through blocking COX-2 gene and protein expressions. Inflammatory disorders are characterized among other events, by the production of significant amounts of free radicals, nitrogen reactive species as well as cytokines such as TNF-a, IL-6, and IL-1b. Among them, TNF-a is a critical cytokine in the inflammatory cytokine network. It can induce the release of IL-6 and IL-1b which enhance the sensitivity of histiocytes to TNF-a in turn. 27) Besides, TNF-a is an endogenous pyrogen which can cause fever and stimulate endotheliocytes and leucocytes to release a series of inflammatory mediators (NO, oxyradical, etc.), and NO could promote TNF-a production in mouse macrophage in turn.
28) It is wellknown that these pro-inflammatory cytokines not only contribute to the efficient control of growth and dissemination of invading pathogens but lead to serious systemic complications such as microcirculatory dysfunction, inflammation, and septic shock.
1) Thus, blocking TNF-a, IL-6, or IL-1b by TNF-neutralizing antibodies, soluble IL-6 receptors, or IL-1 receptor antagonists has been highly successful in some inflammatory diseases. Our results showed that cornuside could significantly suppress TNF-a, IL-6, and IL-1b productions. However, the inhibitory effect of cornuside on TNF-a production was relatively weak compared with that on IL-6 and IL-1b productions. Protein expressions of these cytokines were also inhibited significantly, which suggests that cornuside exerts its anti-inflammatory effects via the repression of pro-inflammatory cytokines at the protein level.
In order to explore the mechanism underlying the anti-inflammatory effect of cornuside, our attention was focused on the NF-kB signal pathway. NF-kB regulates the expressions of gene encoding pro-inflammatory inducible enzymes, such as iNOS, COX-2, and other inflammatory-related proteins. 15) The current study demonstrated that the translocation of activated NF-kB to the nucleus as well as the phosphorylation and degradation of IkB-a is significantly inhibited by cornuside. These data indicate that cornuside may inhibit NF-kB activation by suppressing the phosphorylation and degradation of IkB-a, and the subsequent translocation of the p65 subunit of NF-kB from the cytosol to the nucleus in LPSinduced RAW 264.7 cells.
The MAPKs family is composed of serine and threonine kinases that are activated in response to diverse extracellular stimuli, and that mediate signal transduction from the cell surface to the nucleus. 29) The MAPKs are divided into three major subgroups: ERK1/2, p38, and JNK1/2. The intracellular signals arising from MAPKs cascades invariably lead to the activation of molecules that regulate cell growth, division, and/or differentiation. As described previously, in the LPS-stimulated signaling pathway of macrophages, MAPKs have been related to the LPS-stimulated iNOS and pro-inflammatory cytokine expressions. 16) According to our data, cornuside was found to decrease concentration-dependently the LPS-stimulated phosphorylations of ERK1/2, p38, and JNK1/2. These results also indicate that among MAPK subtypes, JNK1/2 is inhibited most potently by cornuside. Therefore, it is postulated that attenuation of the phosphorylations of these MAPKs by cornuside might contribute to the inhibition of inflammatory reactions in LPS-stimulated RAW 264.7 cells. Meanwhile, even if different types of cells were used in the various experimental conditions, numerous papers have suggested that MAPKs can participate in the regulation of NF-kB transcriptional activity. [30] [31] [32] For example, activation of p38 but not ERK1/2 by LPS results in the NFkB activation and the subsequent expression of iNOS and NO release in macrophages. 32) From this, it is reasonable to assume that p38 suppression by cornuside might cause the inhibition of NF-kB pathway in LPS-elicited RAW 264.7 cells. However, as there is no direct evidence to support this assumption in the present study, further investigations on the action mode of cornuside are needed.
Plants are an important source of drugs, which chemically leads to the identification of novel anti-inflammatory agents. Recently, the natural compounds, such as biochanin-A, 33) ephedrannin B, 34) fraxinellone, 35) and zedoarondiol, 36) have been reported to ameliorate LPS-induced inflammatory response by downregulating the activities of NF-kB and MAPKs. Likewise, our findings show that cornuside inhibits the LPS-stimulated expressions of iNOS and COX-2 with the attendant reduction of NO, PGE 2 , TNF-a, IL-6, and IL-1b productions in RAW 264.7 cells. Furthermore, our molecular data suggest that cornuside attenuates these pro-inflammatory modulators in vitro by preventing NF-kB activation via blocking IkB-a phosphorylation and suppressing all three MAPKs activation. These results implicate that cornuside functions as an inhibitor of upstream mediators including IkB kinase-b in the so-called "canonical" NF-kB pathway as well as an inhibitor of upstream mediators including MAPK kinase related to the phosphorylations of MAPKs in MAPK cascades. 34, 37) However, this inhibition by cornuside is different from the result that down-regulation of inflammatory mediators by biochanin-A in RAW 264.7 cells has been attributed to suppression of the phosphorylations of p38 and activating transcription factor-2.
33) Additionally, ephedrannin B-mediated suppression of inflammatory response occurs through inhibition of p38, but not ERK1/2 and JNK1/2. 34) As for fraxinellone, this compound exerts anti-inflammatory actions by attenuating the phosphorylation of ERK1/2, whereas the phosphorylations of JNK1/2 and p38 are unaffected. 35) On the other hand, suppression of all three MAPK components by cornuside in this study is similar to that by zedoarondiol in LPS-stimulated RAW 264.7 cells. 36) In conclusion, cornuside could be a good candidate for the treatment of various human inflammatory disorders because the inhibitory effect of cornuside on pro-inflammatory mediators is comparable to other previously-characterized compounds such as curcumin, epigallocatechin gallate, and resveratrol.
38) The potential therapeutic use of cornuside in inflammatory diseases could be evaluated if the data were confirmed in vivo. Accordingly, the current data provide a partial description of the mechanism underlying the antiinflammatory effects of cornuside.
